Clinical trial of tendon regenerative scaffold for repairing human extensor tendon defect

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037598

Enrollment

Unknown

Registered

2020-08-29

Start date

2020-08-31

Completion date

Unknown

Last updated

2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tendon defect

Interventions

cases:Biomaterial implantation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged 16to 60 years, with extensor tendon defect (>=3cm)

Exclusion criteria

Exclusion criteria: 1. poor general condition; 2. within three months of local hormone therapy; 3. insufficient function of vital organs like heart, lung, brain and kidney; 4. hematological diseases or tendency of hemorrhage; 5. drug addiction (including drug, anesthetics and alcohol); 6. tendency to suffer scar or allergy; 7. infectious viral diseases; 8. general or focal infections; 9. women during pregnancy and lactation, or with plan to get pregnant within one year; 10. mental diseases, unable to cooperate operations; 11. congenital malformations of vital organs; 12. participation in other clinical trials; 13. the tendon defect is as a result of malignant tumor resection; 14. rejection of the repair method of tissue engineering.

Design outcomes

Primary

Measure	Time frame
Strickland TAM;	—

Secondary

Measure	Time frame
histology analysis;transmission electron microscope;	—

Countries

China

Contacts

Public ContactLiu Wei

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

liuwei_md@126.com+86 13641957463

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026